BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
9/26/22 Arcutis (ARQT) ARQ-154 for Psoriasis Subscribers Only Subscribers Only Subscribers Only
9/23/22 AstraZeneca (AZN) AZD8233 for Dyslipidemia / Hypercholesterolemia Subscribers Only Subscribers Only Subscribers Only
9/22/22 Spectrum Pharmaceuticals (SPPI) Poziotinib for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
9/22/22 Oncopeptides AB (ONCO) Pepaxto for Multiple Myeloma (MM) Subscribers Only Subscribers Only Subscribers Only
9/22/22 Ferring Rebyota for Clostridium difficile-Associated Diarrhea/Infection (CDAD/CDI) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
09/27/22 Subscribers Only Subscribers Only Regulatory - Supplemental Approval (Europe)
09/27/22 Subscribers Only Subscribers Only Trial Data - Top-Line Results
09/28/22 Subscribers Only Subscribers Only Trial Data - Other
09/28/22 Subscribers Only Subscribers Only Trial Data - Updated Results
09/28/22 Subscribers Only Subscribers Only Trial Data - Other
Back to the top Back to the top